What types of research require IBC oversight?

IBC oversight applies to research involving recombinant or synthetic nucleic acid molecules, including human gene transfer and gene therapy trials. While the NIH Guidelines center on recombinant and synthetic nucleic acids, many institutions extend their Institutional Biosafety Committee’s scope to related biohazards such as pathogens, infectious materials, and biological toxins. BRANY’s IBC experts help your team determine which work falls under the Guidelines and identify the appropriate containment level for the study.